Discovering the Potential Drug Target and Biomarker for Topoisomerase IIb

Target Name: TOP2B

NCBI ID: G7155

TOP2B

Discovering the Potential Drug Target and Biomarker for Topoisomerase IIb

Topoisomerase IIb (TOP2B) is an enzyme involved in the repair of DNA double-strands, which is crucial for the maintenance of genetic integrity. The encoded by the top gene, topoisomerase IIb (TOP2B) is a 26 kDa protein that is expressed in various cell types of the human body, including blood cells, tissues, and organs. The protein plays a vital role in DNA double-strand repair, which is critical for the survival of cells and the transmission of genetic information from one generation to the next.

Recent studies have identified TOP2B as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will explore the current research on TOP2B and its potential as a drug target and biomarker.

Potential Drug Target

TOP2B has been identified as a potential drug target due to its unique structure and its involvement in DNA double-strand repair. Several studies have shown that inhibiting the activity of TOP2B can lead to the disruption of DNA double-strand repair, which can result in the development of genetic mutations and the progression of diseases.

One of the most promising strategies for targeting TOP2B is the use of small molecules, such as inhibitors or modulators, that can inhibit the activity of the enzyme. Several studies have shown that inhibitors of TOP2B have the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Biomarker

TOP2B has also been identified as a potential biomarker for several diseases due to its unique expression patterns. The expression of TOP2B has been shown to be affected by various factors, including age, gender, and environmental factors. Several studies have shown that the expression of TOP2B is sensitive to various environmental factors, including temperature, pH, and supplementation with certain nutrients, which suggests that it could be a sensitive biomarker.

In addition, several studies have shown that the levels of TOP2B are regulated by various signaling pathways, including TGF-灏? and NF-kappa-B signaling pathways. These findings suggest thatTOP2B could be a biomarker for diseases associated with these signaling pathways, such as cancer and neurodegenerative diseases.

Conclusion

In conclusion, TOP2B is a protein involved in the repair of DNA double-strands that has been identified as a potential drug target and biomarker for various diseases. The inhibition of the activity of TOP2B has been shown to lead to the disruption of DNA double-strand repair, which can result in the development of genetic mutations and the progression of diseases. Additionally, several studies have shown that TOP2B is a sensitive biomarker for various environmental factors and regulated by various signaling pathways, which suggests that it may have the potential to serve as a diagnostic or therapeutic target in various diseases. Further research is needed to fully understand the potential of TOP2B as a drug target and biomarker.

Protein Name: DNA Topoisomerase II Beta

Functions: Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand. Plays a role in B-cell differentiation

The "TOP2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TOP2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets